Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PolyPid Ltd. - Ordinary Shares
(NQ:
PYPD
)
6.740
+0.430 (+6.81%)
Delayed Quote
Updated: 11:47 AM EST, Nov 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PolyPid Ltd. - Ordinary Shares
< Previous
1
2
3
4
Next >
What PolyPid (PYPD) Said on Its Q3 Earnings Call
↗
Today 10:15 EST
PolyPid (NASDAQ:PYPD) is approaching a Nov. 28 U.S. regulatory decision on D-PLEX100, its experimental product for preventing surgical site infections in patients undergoing colorectal surgery, while...
Via
MarketBeat
Topics
Earnings
PolyPid Targets 2027 D-PLEX100 Launch, Unveils Diabetic Foot Infection Program
↗
October 29, 2026
PolyPid (NASDAQ:PYPD) outlined plans to expand its commercial and development strategy through 2030 at an investor day, as the company approaches a November 28, 2026, FDA action date for its D-PLEX100...
Via
MarketBeat
PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data
↗
October 04, 2026
PolyPid (NASDAQ:PYPD) is approaching a November 28 PDUFA date for D-PLEX100, its lead product candidate for preventing surgical site infections in patients undergoing colorectal surgery, Chief...
Via
MarketBeat
Topics
Bonds
PolyPid (PYPD) Q2 2026 Earnings Call Transcript
↗
August 19, 2026
FDA accepts D-PLEX100 application with Priority Review, setting November approval target.
Via
The Motley Fool
Topics
Earnings
PolyPid Ltd (NASDAQ:PYPD) Reports Q4 2025 Results, Focus on D-PLEX₁₀₀ Partnership and Regulatory Progress
↗
February 11, 2026
Via
Chartmill
PolyPid Q2 Earnings Call Highlights
↗
August 12, 2026
PolyPid (NASDAQ:PYPD) said its second-quarter 2026 was marked by the FDA’s acceptance of its new drug application for D-PLEX100 and a commercialization agreement with Azurity Pharmaceuticals covering...
Via
MarketBeat
Topics
Earnings
PolyPid (PYPD) Q1 2026 Earnings Transcript
↗
May 13, 2026
PolyPid (PYPD) Q1 2026 Earnings Transcript
Via
The Motley Fool
PolyPid Q1 Earnings Call Highlights
↗
May 13, 2026
PolyPid (NASDAQ:PYPD) said its first quarter marked a transition from late-stage clinical development toward regulatory submission and commercial preparation for D-PLEX100, its lead product candidate...
Via
MarketBeat
Topics
Earnings
PolyPid (PYPD) Q4 2025 Earnings Call Transcript
↗
February 11, 2026
PolyPid (PYPD) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
A Look Ahead: PolyPid's Earnings Forecast
↗
May 13, 2025
Via
Benzinga
Earnings Scheduled For February 12, 2025
↗
February 12, 2025
Via
Benzinga
PolyPid Soars 3.4% on Pivotal FDA Endorsement for D-PLEX100 NDA
December 03, 2025
Jerusalem, Israel – December 3, 2025 – PolyPid Ltd. (NASDAQ: PYPD) witnessed a significant surge in its stock price today, gaining 3.4% following the announcement of supportive feedback from the U.S....
Via
MarketMinute
An Overlooked Crisis in Hospitals Could Be Pharma’s Next Great Opportunity
October 13, 2025
Via
AB Newswire
These stocks are moving in today's pre-market session
↗
August 18, 2025
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
Earnings Scheduled For November 13, 2024
↗
November 13, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
August 18, 2025
Via
Benzinga
Cisco To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Thursday
↗
August 14, 2025
Via
Benzinga
POLYPID LTD (NASDAQ:PYPD) Reports Q2 2025 Results with Mixed Market Reaction Despite Positive Phase 3 D-PLEX₁₀₀ Data
↗
August 13, 2025
PolyPid reports Q2 2025 results with positive Phase 3 data for D-PLEX₁₀₀, but EPS miss and no revenue. Stock dips slightly pre-market.
Via
Chartmill
PolyPid’s Game-Changing 60-Day GLP-1 Platform Could Disrupt $100B Weight Loss Market
July 15, 2025
Via
AB Newswire
Earnings Scheduled For August 13, 2025
↗
August 13, 2025
Via
Benzinga
With Fresh Funding and Strong Phase 3 Data, PolyPid Advances Towards FDA Approval
June 18, 2025
Surgical infection prevention breakthrough demonstrates 58% infection reduction as company secures funding through regulatory approval (NASDAQ:PYPD)*
Via
News Direct
These stocks have an unusual volume in today's session
↗
June 10, 2025
Volume analysis on 2025-06-10: stocks with an unusual volume in today's session.
Via
Chartmill
Nano-Cap PolyPid's Lead Drug Candidate Cuts Surgical Infection Risk by 38% In Phase 3 Trial
↗
June 09, 2025
PolyPid's D-PLEX100 met all key endpoints in a Phase 3 trial, showing a 38% drop in infection or death after colorectal surgery vs. standard care.
Via
Benzinga
Why Circle Internet Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
↗
June 09, 2025
Via
Benzinga
This Excelerate Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
↗
June 05, 2025
Via
Benzinga
Q1 Virtual Investor Summit: On-Demand Presentations Now Live
March 18, 2025
Via
ACCESS Newswire
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
February 27, 2025
Via
ACCESS Newswire
Kemper To Rally More Than 25%? Here Are 4 Top Analyst Forecasts For Thursday
↗
December 26, 2024
Via
Benzinga
Earnings Scheduled For May 14, 2025
↗
May 14, 2025
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
